AHA Center for Health Innovation Market Scan

AHA Center for Health Innovation’s Market Scan articles provide insights and analysis on the field’s latest developments in health care disruption, transformation and innovation.

Read the latest newsletters and subscribe to Market Scan.

Follow us to learn more.

The recently released AHA 2024 Environmental Scan offers a wealth of data and context on these challenges to assist health care leaders in their strategic planning as they reshape the future of health care.
CVS Health plans to launch its CVS CostVantage and CVS Caremark TrueCost programs in 2025. CostVantage will define the drug cost and related reimbursement with contracted PBMs and payers, CVS noted in a statement.
A new AHA Center for Health Innovation report, “Leveling the Playing Field in Health Equity Investing,” explores the challenges these entrepreneurs face, how some venture capital (VC) funds are expanding opportunities for underrepresented startups and how the field can benefit.
To truly engage patients in shared decision-making and provide proper informed consent, clinicians not only need the appropriate risk data, but they need to share it with patients and document these conversations.
AHA’s recently released 2024 Health Care Workforce Scan provides a wealth of examples of how provider organizations are piloting new care models and leveraging existing and emerging digital technologies to augment, support and streamline workforce roles.
Health systems must find a way to close the gap between supply and demand for care. The solution is to reinvent the nature of care delivery, according to a new AHA Knowledge Exchange report, “Reinvention to Build a Future-Ready Health Care Workforce.”
Having recently added two new health system partners and leveraged the Amazon Prime membership model, Amazon's One Medical is connecting with employers and the roughly one-third of consumers who do not have a primary care doctor.
The newly released fourth and final part of the Strategic Investment in Health Care Innovation series from Concord Health Partners and the AHA Center for Health Innovation explains “Why Growth Equity is Increasingly a Good Fit for Innovation Investors.”